py and immediately are less confused and have improved brain functioning, but the effect generally fades as the disease progresses.
In their experiment, Gelbard's team was able to stop the harmful effects of Tat in neurons from mice by using the drug dantrolene, which blocks the ryanodine receptor. While the work offers a new target in the search for a drug that could be used in people to stop the effects of HIV dementia, Gelbard cautions that dantrolene has side effects and would not be appropriate.
"A lot of people are under the impression that HIV has been 'solved,' that somehow, it's no longer a problem. But the disease never went away, and it's a huge problem," said Gelbard, who is professor of Neurology, Pediatrics, and Microbiology and Immunology.
"There are a fair number of similarities between this brain disease and other diseases, such as Parkinson's or Alzheimer's," said Gelbard. "We hope that what we are learning can be applied to other diseases as well."
'/>"/>
Page: 1 2 3 4 Related medicine news :1.
Researchers Tackle CLL, Diabetes and Trauma-Hemorrhage
2.
Researchers Use New Method to Control Bleeding in Hemophilia3.
Stem cells with potential to regenerate injured liver tissue identified by Penn researchers4.
Protein can nurture or devastate brain cells, depending on its friends, researchers find5.
Researchers find stem cells from monkey teeth can stimulate growth and generation of brain cells6.
Battling Bacteria in the Blood: U-M Researchers Tackle Deadly Infections7.
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting8.
USC researchers identify key mechanism that regulates the development of stem cells into neurons9.
Cornell researchers study showing evidence of a major environmental trigger for autism10.
Maastricht University researchers produce neural fingerprint of speech recognition11.
Researchers aim to over-stress already taxed mantle cell lymphoma cells